Janjaes LS Syrup is a combination pharmaceutical formulation containing Levosalbutamol (1mg/5ml), Ambroxol (30mg/5ml), and Guaifenesin (50mg/5ml), designed for the symptomatic treatment of respiratory conditions characterized by bronchospasm and excessive mucus production. Levosalbutamol, a selective β2-adrenergic receptor agonist, acts as a bronchodilator by relaxing the smooth muscles of the airways, thereby facilitating easier breathing in conditions such as asthma and chronic obstructive pulmonary disease (COPD). Ambroxol serves as a mucolytic agent, promoting the breakdown and clearance of viscous mucus, which enhances expectoration and improves airway patency. Guaifenesin functions as an expectorant, increasing the volume and reducing the viscosity of bronchial secretions, thereby aiding in the effective clearance of mucus from the respiratory tract. The synergistic action of these three active ingredients makes Janjaes LS Syrup effective in relieving cough, chest congestion, and dyspnea associated with acute and chronic respiratory disorders. It is indicated for use in adults and pediatric patients under medical supervision. Caution is advised in patients with hypersensitivity to any components, cardiovascular disorders, or hyperthyroidism. Janjaes LS Syrup should be used as directed by a healthcare professional to ensure optimal therapeutic outcomes and minimize potential adverse effects.